Home > Animal Health and Nutrition > Veterinary Medical Devices > pet dna testing market
Get a free sample of Pet DNA Testing Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Pet DNA Testing Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The dogs segment held the highest market share of 72.4% in 2023 as dogs boast a wide array of breeds and genetic backgrounds, compelling owners to turn to DNA tests for a comprehensive understanding of their pets' lineage.
The global market was worth USD 351.6 million in 2023 and is poised to remarkably grow at a rate of 9% through 2032, owing to technological advancements in genetic testing, particularly in genomics.
In 2023, North America pet DNA testing market reached a value of USD 139.2 million, with a projected CAGR of 8.9% from 2024 to 2032, backed by high rate of pet ownership, advanced veterinary care infrastructure, and a growing awareness among pet owners regarding proactive pet health management.
Ancestry, Basepaws, Inc. (Zoetis), DNA MY DOG (Canadian Dog Group Ltd.), Dognomics (Clinomics), Embark Veterinary, Inc., FidoCure (OHC), GenSolDiagnostics, LLC, Neogen Corporation, Orivet Genetic Pet Care Ltd., and Wisdom Panel (Mars, Inc.).